{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:44:11Z","timestamp":1783824251155,"version":"3.55.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.16447","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T15:41:59Z","timestamp":1575301319000},"page":"e1916447","source":"Crossref","is-referenced-by-count":6,"title":["Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017"],"prefix":"10.1001","volume":"2","author":[{"given":"Claire A.","family":"Lawson","sequence":"first","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zaccardi","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry P.","family":"McCann","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom"},{"name":"Leicester NIHR Biomedical Research Centre, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, United Kingdom"},{"name":"Leicester NIHR Biomedical Research Centre, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh T.","family":"Kadam","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, United Kingdom"},{"name":"Department of Health Sciences, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"issue":"1","key":"zoi190622r1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: insights from yesterday, today, and future trends.","volume":"20","author":"Rowley","year":"2017","journal-title":"Popul Health Manag"},{"issue":"10","key":"zoi190622r2","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics, 2017 update: a report from the American Heart Association.","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"zoi190622r3","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update.","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"zoi190622r4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"zoi190622r5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ejhf.2018.20.issue-5","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.","volume":"20","author":"Seferovic","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"zoi190622r6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population.","volume":"119","author":"From","year":"2006","journal-title":"Am J Med"},{"issue":"1","key":"zoi190622r7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jchf.2017.08.020","article-title":"Association between type 2 diabetes and all-cause hospitalization and mortality in the UK general heart failure population: stratification by diabetic glycemic control and medication intensification.","volume":"6","author":"Lawson","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"4","key":"zoi190622r8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ejhf.44","article-title":"Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? an observational study from the Swedish Heart Failure Registry.","volume":"16","author":"Johansson","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"zoi190622r9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2337\/dc17-0697","article-title":"Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis.","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi190622r10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1479164112471064","article-title":"Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology.","volume":"10","author":"Cubbon","year":"2013","journal-title":"Diab Vasc Dis Res"},{"issue":"5","key":"zoi190622r11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2337\/dc16-2016","article-title":"Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi190622r12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.2017.19.issue-1","article-title":"In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.","volume":"19","author":"Targher","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"zoi190622r13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.diabres.2014.03.015","article-title":"Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry.","volume":"104","author":"Carrasco-S\u00e1nchez","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"zoi190622r14","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2337\/dc18-0831","article-title":"Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988-2015.","volume":"41","author":"Cheng","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"zoi190622r15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people.","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"27","key":"zoi190622r16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"zoi190622r17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00059-008-3115-3","article-title":"Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms.","volume":"33","author":"Saunders","year":"2008","journal-title":"Herz"},{"issue":"8","key":"zoi190622r18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jchf.2018.01.009","article-title":"Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2.","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail"},{"key":"zoi190622r19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejim.2018.08.011","article-title":"Type 2 diabetes increases the risk of hospital admission for heart failure and reduces the risk of in hospital mortality in Spain (2001-2015).","volume":"59","author":"Mu\u00f1oz-Rivas","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"1","key":"zoi190622r20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2337\/dc17-0544","article-title":"Short- and long-term prognosis of patients with acute heart failure with and without diabetes: changes over the last three decades.","volume":"41","author":"van den Berge","year":"2018","journal-title":"Diabetes Care"},{"key":"zoi190622r21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","article-title":"Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure registry.","volume":"182","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Am Heart J"},{"issue":"5","key":"zoi190622r22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.003023","article-title":"Mortality among patients hospitalized with heart failure and diabetes mellitus: results from the national inpatient sample 2000 to 2010.","volume":"9","author":"Win","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"zoi190622r23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bcp.2010.69.issue-1","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review.","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"zoi190622r24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2337\/diacare.28.1.20","article-title":"Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.","volume":"28","author":"Maru","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"zoi190622r25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/dme.2010.27.issue-2","article-title":"A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data.","volume":"27","author":"de Lusignan","year":"2010","journal-title":"Diabet Med"},{"issue":"3","key":"zoi190622r26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2337\/dc16-1616","article-title":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups.","volume":"40","author":"Wright","year":"2017","journal-title":"Diabetes Care"},{"issue":"11","key":"zoi190622r27","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Tutorial in biostatistics: competing risks and multi-state models.","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"issue":"8","key":"zoi190622r29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","article-title":"Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"zoi190622r30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Programme.","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"9","key":"zoi190622r31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death.","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi190622r33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi190622r34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes.","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"10166","key":"zoi190622r35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"zoi190622r36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"zoi190622r37","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/dom.2019.21.issue-5","article-title":"Heart failure and type 2 diabetes: from cardiovascular outcome trials, with hope.","volume":"21","author":"Giugliano","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"zoi190622r38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","article-title":"Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.","volume":"168","author":"Cheng","year":"2014","journal-title":"Am Heart J"},{"issue":"22","key":"zoi190622r39","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi190622r40","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy.","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi190622r41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes.","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"issue":"10193","key":"zoi190622r42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"zoi190622r43","doi-asserted-by":"publisher","first-page":"s172","DOI":"10.1016\/j.cjca.2017.07.336","article-title":"Empagliflozin (EMPA) reduces heart failure outcomes irrespective of blood pressure (BP), low density lipoprotein cholesterol (LDL-C) and HBA1c control.","volume":"33","author":"Fitchett","year":"2017","journal-title":"Can J Cardiol"},{"issue":"2","key":"zoi190622r44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/cvr\/cvy295","article-title":"Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies.","volume":"115","author":"Chin","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"23","key":"zoi190622r45","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1016\/j.jacc.2018.03.009","article-title":"Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 Study.","volume":"71","author":"Kosiborod","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"zoi190622r46","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction.","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi190622r47","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"issue":"7","key":"zoi190622r48","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00125-016-3956-x","article-title":"SGLT2 inhibition and cardiovascular events: why did EMPA-REG outcomes surprise and what were the likely mechanisms?","volume":"59","author":"Sattar","year":"2016","journal-title":"Diabetologia"},{"issue":"12","key":"zoi190622r49","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/obr.v19.12","article-title":"Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms.","volume":"19","author":"Lee","year":"2018","journal-title":"Obes Rev"},{"issue":"12","key":"zoi190622r50","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"zoi190622r51","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2468-2667(19)30108-2","article-title":"20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study.","volume":"4","author":"Lawson","year":"2019","journal-title":"Lancet Public Health"},{"key":"zoi190622r52","doi-asserted-by":"publisher","first-page":"f659","DOI":"10.1136\/bmj.f659","article-title":"The Quality and Outcomes Framework: where next?","volume":"346","author":"Gillam","year":"2013","journal-title":"BMJ"},{"key":"zoi190622r28","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"zoi190622r32","volume-title":"Type 2 Diabetes in Adults: Management (NG28)","author":"National Institute for Health and Care Excellence","year":"2015"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2756109\/lawson_2019_oi_190622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T15:42:01Z","timestamp":1575301321000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2756109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.16447","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]}}}